Electrospray ionization raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-08-22 and is reviewed periodically as new material appears.
Identity and purity of Semax are established mainly by reversed-phase high-performance liquid chromatography coupled with mass spectrometry. The chromatographic trace gives a purity estimate as a percentage of total peak area, while electrospray or matrix-assisted laser desorption ionization confirms the molecular mass against the calculated value. Amino acid analysis and sequence-specific fragmentation provide further confirmation when a supplier's chain of custody is unclear. Vendors frequently quote a purity figure without stating the detection wavelength or the integration method, which limits how far one number can be compared with another.
Stability depends heavily on physical state. Lyophilized powder held dry, cold and dark retains its content over long periods, whereas dissolved peptide begins to change within days at room temperature. The most cited degradation route is oxidation of the methionine residue, which converts the peptide to a sulfoxide form that elutes differently on chromatography. Hydrolysis of amide bonds and adsorption onto container walls contribute smaller losses. Buffers that exclude oxygen from the headspace slow the oxidation pathway, but no single condition prevents all change indefinitely.
Practical handling follows from those properties. Bulk material is best divided into single-use portions soon after receipt, because each thaw exposes the whole container to moisture and temperature cycling. Vials should be allowed to reach room temperature before opening to prevent condensation on the powder. Low-binding plasticware reduces loss of dilute solutions, and sterile filtration is used when a preparation must remain free of microbial growth. Records of batch number, reconstitution date and storage history are what allow a later analytical result to be interpreted meaningfully.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It corresponds to the ACTH(4-7) fragment extended at the C-terminus by a Pro-Gly-Pro tripeptide, an addition intended to slow enzymatic breakdown. The molecular formula is C37H51N9O10S and the molecular mass is approximately 814 daltons. In the literature it is often described as an ACTH(4-10) analog, although that label reflects a naming convention as much as a precise structural relationship. The compound was developed in Russia and remains most closely associated with that research tradition.
Laboratory descriptions of the material are consistent across suppliers. It appears as a white to off-white lyophilized powder that dissolves readily in water and in polar organic solvents such as dimethyl sulfoxide. Aqueous solutions are clear and colorless at low concentrations. Because the peptide contains methionine, oxidation at the sulfur atom is a recognized degradation pathway, and handling notes usually call for protected, desiccated storage. Reported purity for research-grade lots is generally above 95 percent as measured by reversed-phase high-performance liquid chromatography.
| Property | Value | Notes |
|---|---|---|
| Typical purity specification | ≥ 95 % of peak area by HPLC | Some suppliers quote 98 % or higher |
| Identity confirmation | Mass spectrometry (electrospray or MALDI) | Observed mass is compared with the calculated mass |
| Common analytical method | Reversed-phase HPLC on a C18 column | Acetonitrile and water gradients with trifluoroacetic acid |
| Primary degradation route | Oxidation of the methionine residue | Yields a sulfoxide that separates cleanly on chromatography |
| Storage of dissolved material | Aliquoted and frozen at −20 °C or below | Single-use aliquots avoid repeated temperature cycling |
Solid material is normally kept at minus 20 degrees Celsius in a sealed, desiccated container. Reconstituted solutions are less stable and are usually divided into single-use aliquots before freezing. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of activity. Light exposure is minimized by using amber glassware or foil wrapping. Published stability data for this peptide are sparse, so recommended storage conditions rest mainly on general practice for short synthetic peptides rather than on dedicated study.
Identity and purity are commonly assessed by reversed-phase high-performance liquid chromatography, with ultraviolet detection near 214 nanometers for the peptide backbone. Mass spectrometry, either electrospray or matrix-assisted laser desorption, confirms molecular mass and detects truncation or modification products. Amino acid analysis can verify composition. Because the sequence contains no strongly absorbing aromatic residue apart from phenylalanine, detection wavelengths are chosen carefully. Purity values above 95 percent are typical for research-grade material.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It is described in the literature as an analogue of the ACTH(4–10) fragment, a short N-terminal portion of adrenocorticotropic hormone that retains some neurotropic activity without the full hormonal effects of the parent peptide. The molecule carries a methionine residue at the N-terminus and two proline residues near the C-terminus, features that shape both its interactions with receptor systems and its chemical stability. The free peptide corresponds to the formula C37H51N9O10S and a molecular mass near 813.9 Da.
The compound was developed in the 1980s at the Institute of Molecular Genetics in Moscow, where it emerged from research on short ACTH fragments and their effects on the central nervous system. Russian pharmaceutical listings describe it as a nootropic and neuroprotective agent, most often formulated as nasal drops. It is not a marketed medicine in the United States or the European Union, and no pharmacopoeial monograph covers it. Consequently, most published clinical experience with the substance originates from a small number of research centres, mainly in Russia and neighbouring countries.
Pharmacological accounts link semax to melanocortin signalling and to modulation of neurotrophic factor expression, particularly brain-derived neurotrophic factor and nerve growth factor. Much of this evidence comes from rodent studies using intranasal delivery, a route chosen because it allows peptides to reach the central nervous system with limited systemic exposure. Whether the same mechanisms operate in humans at comparable magnitude remains an open question. The precise receptor or receptors responsible for the reported behavioural and neuroprotective effects have not been conclusively identified.
Semax binds to melanocortin receptors and is thought to influence neuronal survival and plasticity rather than to act through the adrenal axis. Laboratory work has shown increased expression of brain-derived neurotrophic factor and nerve growth factor in treated tissue. Changes in c-Fos, a marker of neuronal activation, have also been reported. Because the peptide is rapidly degraded by peptidases, its effects are generally attributed to downstream signaling cascades rather than to sustained receptor occupancy.
Published studies are dominated by animal models of stroke, ischemia, and cognitive impairment, with a smaller number of human trials conducted in Russia. Many of the human reports are small, single-center, and published in Russian-language journals, which limits independent scrutiny. Outcome measures vary between studies and often rely on clinician-rated scales rather than objective biomarkers. Systematic reviews have noted the methodological weaknesses and called for larger, preregistered trials before firm conclusions can be drawn.
Claims about enhanced focus, memory, or mood in healthy people rest mostly on anecdotal reports and community discussion rather than on controlled data. It remains unclear whether any cognitive benefit observed in patients recovering from brain injury would extend to uninjured users. Dose-response relationships, long-term safety, and interactions with other drugs are not well characterized in the peer-reviewed literature. Questions about optimal route of administration and treatment duration likewise remain open.
Meitnerium has no stable or naturally occurring isotopes. Several radioisotopes have been synthesized in the laboratory, either by fusing two atoms or from the decay of heavier elements. Eight isotopes of meitnerium have been reported with mass numbers 266, 268, 270, and 274–278, two of which, 268Mt and 270Mt, have unconfirmed metastable states. A ninth isotope, 282Mt, is unconfirmed. Most of these decay by alpha emission, though some undergo spontaneous fission.
Glucagon is a hormone that generally opposes the action of insulin. It increases blood glucose by stimulating the production of glucose in the liver via glycogenolysis (breakdown of glycogen) and gluconeogenesis (production of glucose from non-carbohydrate sources). Glucagon also increases the breakdown of lipids and amino acids and the production of ketones. Unlike currently approved weight loss drugs, glucagon receptor agonists increase energy expenditure. Combination GLP-1/glucagon receptor agonists provide the thermogenic benefits of glucagon activation while almost eliminating hyperglycemia induced by glucagon receptor activation. Several such drugs have reached human trials for obesity, diabetes, and non-alcoholic fatty liver disease but adverse effects have hampered development. The most advanced of these drugs is mazdutide which is in a phase III trial as of 2023.
=== Insect mouthparts === Insect mouthparts show many examples of convergent evolution. The mouthparts of different insect groups consist of a set of homologous organs, specialised for the dietary intake of that insect group. Convergent evolution of many groups of insects led from original biting-chewing mouthparts to different, more specialised, derived function types. These include, for example, the proboscis of flower-visiting insects such as bees and flower beetles, or the biting-sucking mouthparts of blood-sucking insects such as fleas and mosquitos.
Sources: en.wikipedia.org
The highest dose of a drug or treatment that does not cause unacceptable side effects. The maximum tolerated dose is determined in clinical trials by testing increasing doses on different groups of people until the highest dose with acceptable side effects is found. Also called MTD. (NCI) Medication
=== Music === The third season includes several original songs, written by the series composer Christopher Lennertz, with two of them being "Rock My Kiss" and "You've Got a License to Drive (Me Crazy)". Both songs are featured respectively in the first ("Payback") and second episodes ("The Only Man in the Sky"), which were performed by Miles Gaston Villanueva. The music video for the latter was released on September 10, 2022. Lennertz delved further for the creation of these new songs by request of Kripke, creating a fictional in-universe musical boyband named Super-Sweet for which Villanueva's character Supersonic is the leader. Wanting to capture the essence of an authentic boyband during the decades of 1990s and 2000s, musical bands like NSYNC, Backstreet Boys, New Kids on the Block and Boyz II Men were researched by Lennertz, intending to understand the vibes that he needed for his tunes and develop a story for the group in the series in order to achieve and develop the fictional band's sound. Given all the profanity the series had, Lennertz needed to ensure that none of the songs had any swearing since "no boyband would ever do that", while also intending to trick the people to make them believe that they already heard and knew about those songs. Lennertz also wrote other two songs being "America's Son" and "Chimps Don't Cry". Both songs are featured in the second episode ("The Only Man in the Sky"), which were performed by Laurie Holden. The latter song got a music video for which it was released on June 17, 2022.
Len Butt (1910–1994), footballer, who played over 370 games, including 150 for Macclesfield Town Sir Alex Ferguson (born 1941), former footballer who played 317 league games and manager of Manchester United for 26 years Chris Nicholl (1946–2024), footballer who played 706 games Terry Nicholl (born 1952 in Wilmslow), footballer, played over 450 games Andy Fanshawe (1963–1992), a British mountaineer, attended Wilmslow Grammar School Liz Blatchford (born 1980 in Wilmslow), professional triathlete Danny Whitaker (born 1980 in Wilmslow), footballer, played 671 games, including 400 for Macclesfield Town Park Ji-sung (born 1981), footballer, played 318 games and 134 league games for Manchester United David Horsey (born 1985), golfer who currently plays on the European Tour, lives in Wilmslow Seren Bundy-Davies (born 1994), track and field sprinter at 400 metres, attended Wilmslow High School Sam James (born 1994 in Wilmslow), rugby union player who has played over 250 games; currently with Sale Sharks Millie Turner (born 1996 in Wilmslow), football defender, who has played 180 games for Women's Super League club Manchester United
On 27 April, Hezbollah leader Naim Qassem stated that the group will not revert to the pre-March status and will respond to Israeli attacks. On 15 May, the truce was extended by Israel and Lebanon for another 45 days. On 1 June, Israel agreed not to hit Beirut's southern suburbs, and Hezbollah agreed not to attack Israel as part of a US proposal, with the cease-fire framework to be expanded to include entire Lebanon. On 3 June, Israel and Lebanon agreed to renew the ceasefire, mediated by the US, and plan to establish "pilot zones". On 4 June, Hezbollah rejected the truce deal announced the previous day and instead demanded a comprehensive truce and full withdrawal of Israel from Lebanon. Israeli forces carried out airstrikes on the Dahieh area in Beirut's southern suburbs on 14 June 2026, targeting what they described as Hezbollah infrastructure in the Dahieh area. The office of the Israeli prime minister said the strikes were in response to rocket fire from Hezbollah toward northern Israel earlier the same day. Lebanese civil defence reported at least three people were killed in the strikes. According to Axios, U.S. officials said Israel had notified the Trump administration before the operation. On 19 June, President Trump said that Israel and Hezbollah agreed to a truce mediated by the US, Qatar and Iran. On 26 June, US Secretary of State Marco Rubio announced a framework deal between Israel and Lebanon that aims to achieve "lasting peace and security" through US mediation.
Sources: en.wikipedia.org
=== Insulin lispro === Insulin lispro, marketed under the brand name Humalog among others, is a modified form of medical insulin used to treat both type 1 and type 2 diabetes. It is administered subcutaneously through injection or an insulin pump. The effects typically begin within 30 minutes and last for about 5 hours. Sometimes, a longer-acting insulin, such as insulin NPH, is also used. Common side effects include low blood sugar, while more serious side effects may include low blood potassium. It is generally considered safe for use during pregnancy and breastfeeding. It functions similarly to human insulin by increasing glucose uptake in tissues and reducing the amount of glucose produced by the liver in gluconeogenesis. Insulin lispro was first approved for use in the United States in 1996. It is a synthetic analogue of human insulin, created by swapping two amino acids. In 2022, it ranked as the 70th most commonly prescribed medication in the United States, with over 9 million prescriptions. Insulin lispro is available under a generic label from Lilly.
This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH−NH2 group of donors with oxygen as acceptor. The systematic name of this enzyme class is L-amino-acid:oxygen oxidoreductase (deaminating). This enzyme is also called ophio-amino-acid oxidase. As of late 2007, 11 structures have been solved for this class of enzymes, with PDB accession codes PDB: 1F8R, PDB: 1F8S, PDB: 1REO, PDB: 1TDK, PDB: 1TDN, PDB: 1TDO, PDB: 2IID, PDB: 2JAE, PDB: 2JB1, PDB: 2JB2, and PDB: 2JB3.
Miner's Bowery Theatre was a vaudeville or variety show theater opened by Senator Henry Clay Miner in 1878. The theater was known for its method of encouraging anyone to get on stage and perform on amateur nights, and for its method of removing bad performers from the stage by yanking them off with a wooden hook. Starting in the 1890s, a stage-prop shepherd's hook was used to pull bad performers bodily from the stage, after audience members shouted, "Give 'im the hook." The phrase, "Give him the hook" originated at Miners Bowery Theatre.
Sources: en.wikipedia.org
Suppliers normally quote a percentage of total chromatographic peak area, most often from reversed-phase HPLC. That figure says nothing about what the remaining percentage contains, and it depends on the detection wavelength used. A mass spectrometry result is a separate and stronger check on identity.
The methionine residue at the start of the chain is vulnerable to oxidation, producing a sulfoxide variant. Amide bonds can also hydrolyze, though more slowly under neutral conditions. Cold storage, oxygen exclusion and minimization of freeze-thaw cycles slow both processes but do not stop them.
A purity number on a certificate does not establish that a powder is the same product as a registered nasal medicine. Counter-ion content, residual solvents and peptide-related impurities may differ between the two. Independent verification is the only way to narrow that gap.
It is registered as a pharmaceutical product in Russia, where it is typically supplied as a nasal solution. In most other countries it is not an approved drug and is traded as a research chemical instead. Approval status depends entirely on the jurisdiction involved.